603O First clinical results from a phase I trial of PRT3789: A first-in-class intravenous SMARCA2 degrader, in patients with advanced solid tumors with a SMARCA4 mutation - Concepedia

Concepedia

Publication | Open Access

603O First clinical results from a phase I trial of PRT3789: A first-in-class intravenous SMARCA2 degrader, in patients with advanced solid tumors with a SMARCA4 mutation

DOI Full Paper Access

12

Citations

0

References

2024

Year

Robin Guo, Afshin Dowlati, Ibiayi Dagogo‐Jack, Julien Vibert, Alexander I. Spira, V. Moreno Garcia, Salman R. Punekar, E. Calvo, G.P. Sonpavde, Mark M. Awad,

Annals of Oncology

No additional data available for this publication yet. Check back later!